| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Feb 05, 2024 | Feb 08, 2024 | Kim Robert Young Chief Medical Officer | Sell | 4D Molecular Therapeutics, Inc. | FDMT | $30.05 | $737,788 | -95.92% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.